YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

Genentech, Roche’s Rituxan Drug Curbs Leukemia

December 11, 2008 | Clinical trials show that Rituxan combined with chemotherapy slowed chronic lymphatic leukemia. Patients had a 41% reduction in the risk of death or their cancer progressing when compared with those treated with chemotherapy alone. Bloomberg 

Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.